AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's . View the basic ABBV stock chart on Yahoo Finance. Change the date range, chart type and compare ABBVIE INC against other companies. AbbVie Inc. stock price, stock quotes and financial overviews from MarketWatch.
Inc. (ABBV ) AbbVie
It constitutes what was once Abbott's pharma division. ABBV stock has suffered in recent months as its old blockbuster drug, Humira, faces patent expirations in many countries. However, AbbVie's drug pipeline has received favorable reviews. For this reason, most analysts believe that a new drug or a combination of future best sellers will more than replace the income lost from generic versions of Humira.
Still, due to the uncertainty, ABBV stock trades at only 8. They also believe the average increase will come in at almost ABBV also offers one key benefit stemming from its former association with Abbott -- dividend aristocrat status.
Walking away from its year streak of payout hikes would put ABBV stock at risk. Hence, one can assume the increases will continue. Given the pressure to raise dividend payments every year, this is a remarkable show of confidence.
Moreover, thanks to a lower stock price and higher dividends, the yield now stands at 5. Investing in ABBV stock now involves some faith. AAPL might seem like a strange choice for a high-growth stocks list. Indeed, both the stock and the earnings projection saw a considerable move lower as iPhone sales fell well short of initial estimates.
Also, laws of mathematics weigh on growth. However, as smartphone prices fall, Apple is working to make itself less iPhone-dependent. It no longer reports iPhone unit sales. Moreover, moves into services and healthcare should bring new sources of revenue. Due to tepid iPhone sales, profit growth for the year will come in at only 0.
But it should reclaim its high-growth status assuming the predicted Although one can place almost every marijuana equity in the "high-growth stocks" category right now, CannTrust stands out with its consistent profitability. Once that listing occurs, more traders can buy it, so it should see some increase at that time. As most know, the Canadian marijuana boom came to an abrupt end in October when the product gained full legal status in Canada.
However, legalization of one form of cannabis, hemp, has reignited this boom south of the Canadian border. CGC have already recovered most of the losses which occurred following legalization in Canada. Even if full legal status does not come soon, both hemp and CBD-related products alone should allow for massive growth across the U.
With its specialty in cannabis oils, CannTrust should benefit. The company also expanded into Europe by becoming the first and only foreign seller of cannabis oil in Denmark beginning in October. At this moment, most cannabis equities could be described as high-growth stocks. QCOM stock has suffered in recent years. A long-running legal dispute with Apple has resulted in the exclusion of Qualcomm chips from the later models of the iPhone. This and other legal battles regarding its licensing practices have weighted on QCOM.
However, a great deal of anticipation surrounds its 5G-capable Snapdragon chip. Carriers have begun to launch 5G networks, and most expect 5G capable phones to see a wide release beginning later this year. As a result, analysts believe that profit increases will again see double-digit increases beginning in After years of profit declines, Wall Street predicts that annual growth will average AbbVie was incorporated in Delaware on April 10, You have selected to change your default setting for the Quote Search.
Health Care Community Rating: Edit Symbol List Symbol Lookup. Go Now Clear List. Key Stock Data 1 Year Target. Intraday Last 52 Weeks High: Data reflects weightings calculated at the beginning of each month. Data is subject to change. Where does ABBV fit in the risk graph?
AbbVie Inc. (ABBV)
Stock analysis for AbbVie Inc (ABBV:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AbbVie Inc. (AbbVie), incorporated on April 10, , is a research-based biopharmaceutical company. The Company is engaged in the discovery, development. AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a.